Sat.Nov 18, 2023 - Fri.Nov 24, 2023

article thumbnail

The Disconnect between R&D Costs and High Drug Prices

MedCity News

Multiple studies have shown no correlation between R&D costs and the launch price of new drugs though that is an argument often used by drugmakers to prevent a cap on pricing. Still, one way to keep costs low, is for organizations to leverage health technology like AI and improve formulary compliance.

Biopharma 131
article thumbnail

Moderna loses a COVID vaccine patent in Europe amid heated clash with BioNTech, Pfizer

Fierce Pharma

With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war. | Moderna pledged to appeal after the European Patent Office ruled one of its patents invalid in the intellectual property battle that spans multiple countries.

346
346
article thumbnail

Texas AG sues Pfiz­er and Tris Phar­ma for adul­ter­at­ed ADHD drug

Pharmaceutical Technology

Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.

Pharma 141
article thumbnail

AstraZeneca joins KRAS push in cancer with Chinese deal

pharmaphorum

AstraZeneca joins KRAS push in cancer with Chinese deal Phil.

130
130
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

New York Proposes Regulations For Stronger Hospital Cybersecurity

MedCity News

New York Governor Kathy Hochul released a proposed set of cybersecurity regulations that require hospitals to establish new policies and procedures to protect themselves from ever-intensifying cyber threats. The state also put aside $500 million in funding to help hospitals upgrade their technology systems to comply with these new rules.

138
138
article thumbnail

To address shortage, Novo Nordisk will cut production of Victoza to boost supply of Ozempic

Fierce Pharma

Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victo | Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victoza to make more Ozempic.

More Trending

article thumbnail

Blow to Moderna as EU nixes mRNA vaccine patent

pharmaphorum

Blow to Moderna as EU nixes mRNA vaccine patent Phil.

116
116
article thumbnail

The Power of Value-Based Digital Transformation for Specialties

MedCity News

There is a huge opportunity for specialties to play a critical role in complementing primary care and tertiary care by transforming into a sustainable model that is preventive, boundaryless, and one that empowers patients and caregivers.

Patients 133
article thumbnail

Pfizer's cost-savings mission continues with office shuffle, job cuts in Ireland

Fierce Pharma

Pfizer, working through a $3.5 billion cost-cutting drive, is not done yet making changes to its workforce in Ireland. | Pfizer's commercial office in Citywest, Dublin, will move to its Ringsend office building, the Irish Independent reports. The moves could end in more job cuts in the company's commercial division.

298
298
article thumbnail

Thousands of men to participate in UK trial for prostate cancer

PharmaTimes

Prostate cancer is responsible for 12,000 deaths every year in the UK - News - PharmaTimes

121
121
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

GSK says new inhaler will help slash its carbon footprint

pharmaphorum

GSK says new inhaler will help slash its carbon footprint Phil.

116
116
article thumbnail

Remote Patient Monitoring: Pioneering Healthcare Through Quality Assurance

MedCity News

RPM has ushered in a new era of healthcare. However, navigating the complexities and challenges of this landscape requires a thoughtful QA strategy.

article thumbnail

Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program

Fierce Pharma

Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR. The lawsuit further accuses the companies of manipulating quality-control testing from 2012 to 2018 to ensure samples received passing grades.

article thumbnail

NHS expands COVID-19 research platform for other major diseases

PharmaTimes

The OpenSAFELY platform will support the discovery of new treatments - News - PharmaTimes

121
121
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Boehringer buys cancer immunotherapy firm T3 for $507m

pharmaphorum

Boehringer buys cancer immunotherapy firm T3 for $507m Phil.

116
116
article thumbnail

HHS Proposes Rule to Bolster Prohibitions Against Discrimination on the Basis of a Disability in HHS Programs

MedCity News

With proposed requirements ranging from accessible self-service kiosks to accessible medical equipment, the impact of this new rule will be wide-ranging with financial, operational, and practical consequences.

Medical 128
article thumbnail

GSK aims to slash carbon emissions with next-generation inhaler

Fierce Pharma

Joining drugmakers like AstraZeneca and Novo Nordisk, GSK is making big strides in its quest to clean up its carbon footprint. | GSK plans to start late-stage trials of a low-carbon version of its metered dose inhaler (MDI) Ventolin utilizing a next-generation propellant in 2024. If the new product proves successful, it has the potential to slash greenhouse gas emissions from Ventolin use by roughly 90%.

278
278
article thumbnail

NHS urges individuals to take up cervical screening invitations

PharmaTimes

Around 3,200 new cases of cervical cancer are diagnosed in the UK every year - News - PharmaTimes

121
121
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New Amgen immunotherapy could treat common solid tumour

European Pharmaceutical Review

Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment. Results from the trial were published in the New England Journal of Medicine.

article thumbnail

Surviving and Thriving in the Age of AI: How Healthcare Leaders Can Learn What They Need to Know

MedCity News

AI may transform health care across the board, but not by itself. It’s a tool, and like any tool, it will work more effectively and more safely in trained hands. As the AI revolution continues to grow, we believe organizations should invest in that training now.

Training 127
article thumbnail

With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics

Fierce Pharma

The U.S. Federal Trade Commission isn’t letting up in its effort to crack down on pharma’s alleged misuse of a patent mechanism in the FDA’s regulatory process. | The U.S. Federal Trade Commission isn't letting up in its effort to crack down on pharma's alleged misuse of a patent mechanism in the FDA's regulatory process. And it's Sanofi’s turn to land in the crosshairs.

Pharma 266
article thumbnail

BHF and UKDRI announce first UK centre for vascular dementia research

PharmaTimes

The centre will help discover new treatments to prevent, halt and cure the condition - News - PharmaTimes

121
121
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Boehringer Ingelheim to advance bacterial cancer therapeutics

European Pharmaceutical Review

Boehringer Ingelheim is acquiring Swiss biotech T3 Pharmaceuticals AG (T3 Pharma), for up to £406 million (450 million CHF), boosting its immuno-oncology portfolio. The pharmaceutical company will utilise T3 Pharmaceutical’s proprietary bacterial cancer therapy platform that consisting that delivers immune-modulating bioactive proteins to cancer cells and tumour micro-environments.

Pharma 115
article thumbnail

Merck Neuroscience Acquisition Brings a Startup With Parkinson’s, ALS Programs

MedCity News

Merck’s acquisition of Caraway Therapeutics adds programs for genetically defined neurodegenerative diseases. One of those programs addresses a target that was the focus of a different startup purchased by Merck in 2019.

Biopharma 125
article thumbnail

After protests, pharma industry reaches 'landmark' drug spending deal with UK government

Fierce Pharma

After blasting the U.K.’s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. | After blasting the U.K.’s drug pricing policy, the pharma industry has secured an improved government spending deal. The agreement will double the annual growth rate for prescription meds over the coming years.

article thumbnail

Alladapt’s allergy treatment receives FDA fast track designation

PharmaTimes

ADP101 is an oral immunotherapy to treat multi-food and single-food allergies - News - PharmaTimes

Food 120
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

Eli Lilly supports Alto Neuroscience in $45m Series C round

Pharmaceutical Technology

The funding will go towards the development of the company's four CNS candidates, with Phase II study data readouts expected by early 2025.

116
116
article thumbnail

What Health Plans Wish the Healthcare Innovation Ecosystem Knew

MedCity News

A California payer lays out the three things she wishes all entrepreneurs knew about how to bring their ideas to market most effectively and initiate successful collaboration.

article thumbnail

AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players

Fierce Pharma

Looking to protect its lucrative immunology drug Rinvoq, AbbVie is suing a clutch of generic drug makers that are attempting to market copycat versions of the blockbuster. | In a lawsuit filed in Delaware federal court Monday, AbbVie accused Sandoz, Hetero Labs, Aurobindo Pharma, Intas Pharmaceuticals and Sun Pharmaceutical of trying to sidestep dozens of patents protecting Rinvoq through the next decade.

article thumbnail

Lab-grown blood vessels could potentially treat strokes and vascular dementia

PharmaTimes

Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes - News - PharmaTimes

120
120
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten